Vandetanib (ZD6474) induces antiangiogenesis through mTOR–HIF-1 alpha–VEGF signaling axis in breast cancer cells
Ling Li,1,* Jingkui Yu,2,* Shuhong Jiao,1 Wei Wang,1 Fen Zhang,1 Shiqing Sun1 1Department of Oncology, Affiliated Tengzhou Central People’s Hospital of Jining Medical University, Zaozhuang, Shandong, China; 2Breast Surgery Department, Affiliated Tengzhou Central People’s Hospita...
Main Authors: | Li L, Yu J, Jiao S, Wang W, Zhang F, Sun S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/vandetanib-zd6474-induces-antiangiogenesis-through-mtor-hif-1-alpha-ve-peer-reviewed-article-OTT |
Similar Items
-
Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy
by: Jie Wei, et al.
Published: (2016-12-01) -
CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling
by: Xiaolin Wan, et al.
Published: (2006-05-01) -
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
by: Hari Deshpande, et al.
Published: (2011-01-01) -
Vandetanib induced photoallergic dermatitis: A case report
by: Gurbet Acar Yüce, et al.
Published: (2018-06-01) -
Cortisol inhibits mTOR signaling in avascular necrosis of the femoral head
by: Yun Liao, et al.
Published: (2017-10-01)